Thierry Pieton - 03 Aug 2026 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: MDT
Reported as of: 03 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Aug 2026, 19:59:06 UTC
Prior SEC filing: 05 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Thierry Pieton filed Form 4 for Medtronic plc (MDT) on 04 Aug 2026.

Key facts

This page summarizes Thierry Pieton's Form 4 filing for Medtronic plc (MDT).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Aug 2026, 19:59.

Change

Previous filing in this sequence was filed on 05 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002056622 Primary reporting owner

Pieton Thierry

Relationship: EVP & Chief Financial Officer
Address: 710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature: /s/ Patricia Walesiewicz, attorney-in-fact
Signature date: 04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Award

Transaction value
Shares: +11,537
Change %: +30%
Price: $0.000000^*
Shares after: 49,645
Date: 03 Aug 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDT transaction Derivative

Performance Share Units

Award

Transaction value
Shares: +28,842
Change %
Price: $0.000000^*
Shares after: 28,842
Date: 03 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 28,842
Exercise price
Footnotes: F3, F4, F5

MDT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +81,945
Change %
Price: $0.000000^*
Shares after: 81,945
Date: 03 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 81,945
Exercise price: $86.68
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

Footnote F2

Includes 534 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Footnote F3

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

Footnote F4

Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

Footnote F5

The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 28,842 shares will be issued. If maximum performance metrics are achieved, 69,221 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

Footnote F6

These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.